NewEdge Advisors LLC lifted its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 9,811.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 99,112 shares of the company's stock after purchasing an additional 98,112 shares during the quarter. NewEdge Advisors LLC's holdings in Oscar Health were worth $1,332,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also made changes to their positions in the company. JPMorgan Chase & Co. increased its stake in Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after buying an additional 8,051,379 shares during the period. BIT Capital GmbH increased its position in shares of Oscar Health by 5,711.6% during the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock worth $60,129,000 after acquiring an additional 4,396,872 shares during the period. Hennessy Advisors Inc. boosted its holdings in Oscar Health by 550.3% in the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after purchasing an additional 3,544,300 shares during the period. Clearbridge Investments LLC acquired a new position in Oscar Health during the 4th quarter worth $19,088,000. Finally, American Century Companies Inc. increased its holdings in Oscar Health by 185.6% during the 4th quarter. American Century Companies Inc. now owns 1,285,204 shares of the company's stock worth $17,273,000 after purchasing an additional 835,144 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.
Oscar Health Stock Up 1.8 %
NYSE OSCR traded up $0.22 during trading on Friday, reaching $12.25. 3,593,852 shares of the company's stock were exchanged, compared to its average volume of 3,893,885. The company has a 50 day moving average price of $13.56 and a two-hundred day moving average price of $14.82. The stock has a market cap of $3.07 billion, a P/E ratio of -612.19 and a beta of 1.75. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, equities research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price objective for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $20.21.
Read Our Latest Stock Report on Oscar Health
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Stories

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.